Skip to main content
. Author manuscript; available in PMC: 2014 Nov 22.
Published in final edited form as: J Acquir Immune Defic Syndr. 2014 Sep 1;67(1):e27–e33. doi: 10.1097/QAI.0000000000000252

Table 2. Severity, composition and accessibility of consecutive 2-year cohorts starting ART in Karonga District, 2005-2012.

Cohort Number of patients (N=8,159) Severity Composition Accessibility

Initiated because of CD4 cell count Initiated in WHO stage 3 (n, %) Initiated in WHO stage 4 (n, %) Mortality at 6 months (n, %) Number of female patients (n, %) Number of patients ≥ 35 years (n, %) Number started in district hospital (n, %) Distance (km) to initiating ART clinic (median, IQR)
2005-2006 1,085 (13.3) 16 (1.5) 401 (37.0) 668 (61.6) 244 (22.5) 653 (60.2) 636 (58.6) 996 (91.8) 10.8 (3.8-30.1)
2007-2008 2,244 (27.5) 151 (6.7) 1,410 (62.8) 682 (30.4) 205 (9.1) 1,309 (58.3) 1,282 (57.2) 1,342 (59.8) 5.2 (3.3-12.9)
2009-2010 2,458 (30.1) 622 (25.3) 1,485 (60.4) 351 (14.3) 122 (5.0) 1,439 (58.5) 1,388 (56.5) 1,190 (48.4) 5.3 (3.1-11.3)
2011-2012 2,372 (29.1) 409 (17.2) 1,719 (72.5) 238 (10.0) 70 (3.0) 1,330 (56.1) 1,469 (62.3) 928 (39.1) 4.6 (3.0-8.5)